EP1670514 - Bibliographic data
ANTITUMOR AGENT COMPRISING A HISTONE DEACETYLASE INHIBITOR AND A TOPOISOMERASE II INHIBITOR
Last update | 10/07/2025 |
---|---|
Legal status | Brevet déchu |
Origin | Euro-PCT |
(73) Holder |
ASTELLAS PHARMA INC. 3-11, Nihonbashi-Honcho 2-chome, Chuo-ku
Tokyo 103-8411
Japon
|
---|---|
(72) Inventors |
NAOE, Yoshinori 4034-18-103, Izumi-cho, Izumi-ku
Yokohama-shi, Kanagawa 245-0016
Japon
SASAKAWA, Yuka c/o Astellas Pharma Inc. 3-11, Nihonbashi-Honcho 2-chome
Chuo-ku, Tokyo 103-8411
Japon
|
(74) Agent |
Mail recipient GILLE HRABAL Patentanwälte Brucknerstrasse 20
40593
Düsserdolf
Allemagne
|
(21) Request number | EP04773539.4 |
---|---|
(22) Request date | 24/09/2004 |
(11) Publication number | EP1670514 |
---|---|
Publication date | 23/06/2010 |
(54) Title of the invention | ANTITUMOR AGENT COMPRISING A HISTONE DEACETYLASE INHIBITOR AND A TOPOISOMERASE II INHIBITOR |
---|---|
(51) International classification | A61P 35/00 |
International classification (before reform) | None |
Claimed priority |
(31) Number: 2003334340
(31) Number: 2003344315 |
---|---|
Initial application | None |
Divisional application | EP10163527.4 /EP2263694 None |
Expected annuity |
Annuity: 7 -
Amount: 90 € -
Due date 30/09/2010
Surtax: 7 - Amount: 18 € - Due date 31/03/2011 |
---|---|
Last annuity | None |
Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2010/2, of 30/06/2010 |
---|---|
History | Publication de la délivrance du brevet européen - Legal date 23/06/2010 Déchéance du brevet d'invention après période de grâce - Legal date 30/09/2010 Entrée en période de grâce du brevet d'invention - Legal date 30/09/2010 |